NCT06785038

Brief Summary

This study will address the significant yet often overlooked problem of HIV among cisgender women. To do this, researchers will adapt and test a multilingual technology-based strategy supporting informed decision-making for PrEP in primary care. Specifically, researchers will use the electronic health record to securely send women multimedia educational materials in English or Spanish about PrEP, and facilitate electronic scheduling of PrEP visits - if women decide they are interested. Choice is critical.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
May 2025Jul 2026

First Submitted

Initial submission to the registry

January 15, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 20, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

May 19, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 19, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

January 15, 2025

Last Update Submit

April 28, 2026

Conditions

Keywords

PrEPcisgender womenprimary careelectronic health record

Outcome Measures

Primary Outcomes (1)

  • PrEP Knowledge

    PrEP knowledge is our primary outcome. We will use an adapted version of an existing PrEP knowledge scale by Walsh (2019). Participants will be asked 13 questions, each with true, false or don't know response options. The number of correct answers will be summed and expressed as percentage correct. Higher scores will represent greater PrEP knowledge.

    Two to 4 weeks after women are sent materials (attention control or EMPOWER Strategy) in their patient portal accounts

Study Arms (2)

Attention Control

OTHER
Behavioral: Attention Control

EMPOWER Strategy

EXPERIMENTAL
Behavioral: EMPOWER Strategy

Interventions

The EMPOWER Strategy will: 1) identify women in primary care; 2) deliver understandable, actionable, and non-stigmatizing PrEP education, in multiple formats and languages, directly and securely to women via the patient portal; 3) enable women to discreetly self-schedule a visit to discuss PrEP options via the patient portal, with either their own PCP or with a female PCP who has years of experience in PrEP delivery; and 4) support PCP counseling via clinical decision support that provides standardized, patient-centered language to guide PrEP discussions and via 'smart sets' to facilitate PrEP prescribing, when desired and appropriate.

Also known as: PrEP Education, PrEP Scheduling, PrEP Counseling Support, PrEP Prescribing Support
EMPOWER Strategy

Women in this arm will be sent, via the patient portal, a CDC patient education material on benefits of physical activity. The material will be in English or Spanish based on patient's language.

Attention Control

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsCisgender women
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must:
  • identify as a cisgender woman
  • be aged 18 years or older
  • speak English or Spanish
  • be a primary care patient at the participating health center
  • have an active patient portal account
  • be HIV negative
  • have never been prescribed PrEP

You may not qualify if:

  • Individuals will be excluded if they have any:
  • \- severe, uncorrectable vision, hearing, or cognitive impairments that would preclude study consent or participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University

Chicago, Illinois, 60611, United States

Location

Study Officials

  • Stacy C Bailey, PhD, MPH

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 15, 2025

First Posted

January 20, 2025

Study Start

May 19, 2025

Primary Completion

February 19, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

All IDP collected throughout the trial will be included.

Shared Documents
SAP
Time Frame
April 2026 for at least 3 years
Access Criteria
We will submit de-identified data to the NIMH Data Archive.
More information

Locations